| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/30/2007 | CN1972603A Process for producing whitish banaba extract, whitish banaba extract and food or drink containing whitish banaba extract |
| 05/30/2007 | CN1970579A High substitution degree carboxymethyl indianbread polysaccharide and its preparation method and uses |
| 05/30/2007 | CN1970538A 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 05/30/2007 | CN1970086A Monomodified PEGylated insulin and its preparation method |
| 05/30/2007 | CN1970070A Oral administered formulation for reducing fat and expelling toxins, preparation process and quality control method thereof |
| 05/30/2007 | CN1970060A Chinese medicinal composition for reducing blood fat and preparation process thereof |
| 05/30/2007 | CN1970059A Medicated wine for treating adiposis |
| 05/30/2007 | CN1970058A Chinese medicinal formulation for treating diabetes |
| 05/30/2007 | CN1970015A Enzymatic extraction method of pawpaw polyphenol |
| 05/30/2007 | CN1970008A Health tea capable of lowering blood pressure and decreasing blood fat and preparation process thereof |
| 05/30/2007 | CN1970002A Method for preparing minipill of 'Xue Fu Zhu Yu' |
| 05/30/2007 | CN1969941A Fox immunity enhancer |
| 05/30/2007 | CN1969918A 口服脂肪乳剂 Oral fat emulsions |
| 05/30/2007 | CN1969889A Enteric-coated multilayer encapsulated probiotic microcapsule and preparation method thereof |
| 05/30/2007 | CN1969882A Sugar-free vitamin oral liquid |
| 05/30/2007 | CN1969863A Vitamin composition used for marine product |
| 05/30/2007 | CN1969855A Pharmaceutical composition having target organ protection function and usage thereof |
| 05/30/2007 | CN1969849A Stable pharmaceutical composition containing pitavastatin calcium and preparation process thereof |
| 05/30/2007 | CN1969833A Dry powder composition containing CoQ10 and preparation process thereof |
| 05/30/2007 | CN1969815A Sustained release agent of curcumin and preparation method thereof |
| 05/30/2007 | CN1969687A Crocodile meat preparation and production process thereof |
| 05/30/2007 | CN1318414C Compound containing structure of o-naphthaquinone and application |
| 05/30/2007 | CN1318412C Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
| 05/30/2007 | CN1318403C Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 05/30/2007 | CN1318402C Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors |
| 05/30/2007 | CN1318392C Improved preparation method of Nagelinei |
| 05/30/2007 | CN1318103C Medical products comprising a haemocompatible coating, production and use thereof |
| 05/30/2007 | CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 05/30/2007 | CN1318086C Use of soluble CTLA4 molecule in preparation of medicine composition for treating rheumatic diseases |
| 05/30/2007 | CN1318042C Application of barbat skullcap in preparing medication for treating diabetes |
| 05/30/2007 | CN1318041C Compositions for weight reduction |
| 05/30/2007 | CN1318034C Drug prepared by mulberry bark extract |
| 05/30/2007 | CN1318025C Composition for pharmaceutical or dietetic use for combating hair loss |
| 05/30/2007 | CN1317979C Modified methionine rich food products and process for their manufacture |
| 05/30/2007 | CN1317958C Hot pepper shortbread for fat-reducing |
| 05/29/2007 | US7223867 Preparation of benzosuberonylpiperidine compounds |
| 05/29/2007 | US7223846 Urocortin proteins and uses thereof |
| 05/29/2007 | US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders |
| 05/29/2007 | US7223835 Cyclic peptide mimetic for treating cancer; anticarcinogenic agents |
| 05/29/2007 | US7223798 treating inflammatory or autoimmune disorders and pulmonary or respiratory tract inflammation |
| 05/29/2007 | US7223791 Function regulator for retinoid relative receptor |
| 05/29/2007 | US7223784 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 05/29/2007 | US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents |
| 05/29/2007 | US7223775 Stabilized ascorbic acid derivatives |
| 05/29/2007 | US7223764 Antilipemic agents; anticholesterol agents |
| 05/29/2007 | US7223763 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 05/29/2007 | US7223758 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 05/29/2007 | US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 05/29/2007 | US7223736 Composition for the prevention and treatment of cachexia |
| 05/29/2007 | US7223591 Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 05/29/2007 | US7223563 Nucleic acids; diagnosing and treating hypophosphatemic disorders; diagnosing tumor induced osteomalacia |
| 05/29/2007 | US7223394 Human antibodies that bind human TNFα |
| 05/29/2007 | CA2340052C Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 05/29/2007 | CA2313504C Folic acid in solid dosage forms |
| 05/29/2007 | CA2275420C Stable liquid mineral ascorbate compositions and methods of manufacture and use |
| 05/29/2007 | CA2247467C Use of piperine as a bioavailability enhancer |
| 05/24/2007 | WO2007058930A1 Human g protein-coupled receptor and modulators thereof for the treatment of obesity and conditions related thereto |
| 05/24/2007 | WO2007058482A1 Novel inhibitors of protein kinase |
| 05/24/2007 | WO2007058381A1 Novel highly functional enzyme having modified substrate-specificity |
| 05/24/2007 | WO2007058346A1 HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON 11-β-HYDROXYSTEROID DEHYDROGENASE TYPE I |
| 05/24/2007 | WO2007058335A1 Use of tak-475 together with ezetimibe for treating hyperlipidemia |
| 05/24/2007 | WO2007058322A1 Basic group-containing compound and use thereof |
| 05/24/2007 | WO2007058105A1 Method for producing pancreas from es cell |
| 05/24/2007 | WO2007057849A2 2,3,4,5-tetrahydroxy-6-sulfooxyhexanoic acid and its metal salts for medical use |
| 05/24/2007 | WO2007057755A1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium |
| 05/24/2007 | WO2007057687A1 Piperazine derivatives and their use in therapy |
| 05/24/2007 | WO2007057329A1 Azaindole-2-carboxamide derivatives |
| 05/24/2007 | WO2007056907A1 TRUNCATED GLUCAGON-LIKE PEPTIDE-1 (sGLP-1) AND ITS PREPARING METHOD AND USE |
| 05/24/2007 | WO2007056846A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 05/24/2007 | WO2007037513A9 Aryl-substituted nitrogen-containing heterocyclic compound |
| 05/24/2007 | WO2006045796A9 Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof |
| 05/24/2007 | WO2006042408A9 Gh secretagogues and uses thereof |
| 05/24/2007 | US20070117860 Bicyclic indolinesulphonamide derivatives |
| 05/24/2007 | US20070117843 Quinoline inhibitors of cGMP phosphodiesterase |
| 05/24/2007 | US20070117842 Polymorph of 4-[3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6- quinolinecarboxamide and a process for the preparation of the same |
| 05/24/2007 | US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 05/24/2007 | US20070117754 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 05/24/2007 | US20070117165 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/24/2007 | US20070116688 Methods of organ regeneration |
| 05/24/2007 | US20070116671 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| 05/24/2007 | US20070116654 Cosmetics |
| 05/24/2007 | US20070113727 Wireless microphone communication system |
| 05/24/2007 | DE20321455U1 Stabilisiertes pharmazeutisches Erzeugnis, das einen amorphen Wirkstoff enthält A stabilized pharmaceutical product which contains an amorphous active ingredient |
| 05/24/2007 | DE102006013623A1 Mittel zur Verminderung des verwertbaren Kaloriengehalts der Nahrung und zur therapeutischen Gewichtsabnahme. Means for reducing the calorie content of the food and usable for therapeutic weight loss. Insbesondere zur Anwendung bei Adipositas (Fettsucht) In particular, for use in obesity (obesity) |
| 05/24/2007 | DE102005056103A1 Agent, useful to treat diabetes, comprises 5-D-fructose-dehydrogenase and glucose isomerase |
| 05/24/2007 | CA2629232A1 Azaindole-2-carboxamide derivatives |
| 05/24/2007 | CA2628996A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 05/24/2007 | CA2627877A1 Human g protein-coupled receptor and modulators thereof for the treatment of obesity and conditions related thereto |
| 05/24/2007 | CA2626092A1 Novel highly functional enzyme having modified substrate-specificity |
| 05/23/2007 | EP1788390A1 Screening method |
| 05/23/2007 | EP1788000A1 Agent for preventing and ameliorating obesity |
| 05/23/2007 | EP1787984A2 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 05/23/2007 | EP1787982A2 11Beta-Hydroxysteroid dehydrogenase type 1 active compounds |
| 05/23/2007 | EP1787970A1 Method of obtaining polyphenolic extracts from cocoa beans, the extracts obtained and their applications |
| 05/23/2007 | EP1787646A2 Novel method of treatment |
| 05/23/2007 | EP1787532A2 Microbial oil mixtures and uses thereof |
| 05/23/2007 | EP1787529A2 Composition and methods using an eutomer |
| 05/23/2007 | EP1786806A1 Dpp-iv inhibitors |
| 05/23/2007 | EP1786774A1 Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/23/2007 | EP1786455A2 Use of intradiscally administered autologous cells producing type i interferon for the treatment of degenerative disc disease |